WHAT: The “Surviving and Thriving” Wellness Conference, hosted by The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center San Antonio empowers cancer patients, both the newly diagnosed and long-term survivors, and their caregivers to learn how to conquer their fears, manage their symptoms and find inspiration in the words of nationally acclaimed speakers.
WHEN: Friday, May 16 (4 p.m.) – Sunday, May 18 (4 p.m.)
The best day for visuals and interviews is Saturday, May 17.
WHERE: El Tropicano Riverwalk Hotel
110 Lexington Ave., San Antonio, TX 78205
VISUALS: For a complete agenda, visit the CTRC website at www.ctrc.uthscsa.edu.
• Cancer survivors participating in art and music therapy, yoga, tai chi, health and beauty classes, and much more.
• Interview opportunities with local cancer survivors and physicians.
• Interview opportunities with nationally acclaimed speakers:
o Scott Burton, a celebrated cancer survivor, comedian and juggler
o Lisa Powell, breast cancer survivor and director of nutrition at Tucson’s renowned Canyon Ranch
o Heidi Adams, Planet Cancer Founder and Executive Director
CONTACT: To arrange interviews in advance:
Jill Byrd, CTRC Assistant Director of News and Information
210-450-5550 – office
210-326-0459 – cellular
To arrange interview on-site:
Mary Jackson, CTRC Wellness Center Director
210 – 274-1638
The Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio, located in San Antonio, Texas, is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of a few elite cancer centers in the country to be named a National Cancer Institute-designated (NCI) Cancer Center, and is one of only three in Texas. CTRC handles more than 120,000 patient visits each year and is a world leader in developing new drugs to treat cancer. The CTRC Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world, and has participated in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.uthscsa.edu.